Cargando…

Yi-qi-yang-yin-tian-sui-fang enhances cisplatin-induced tumor eradication and inhibits interleukin-7 reduction in non-small cell lung cancer

Traditional Chinese Medicine (TCM) has been recognized to be conducive to enhancing the efficiency and reducing the side effects in the whole course of cancer treatment. The mechanisms of TCM/chemotherapy combination involved with interleukin-7 (IL-7) potentially enhance immune responses against tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Bin, Wu, Xinlin, Yang, Qiong, Huang, Yuanyuan, Wang, Fang, Gong, Yuxin, Liu, Junfang, Shi, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597844/
https://www.ncbi.nlm.nih.gov/pubmed/31138762
http://dx.doi.org/10.1042/BSR20190052
_version_ 1783430655448711168
author Ke, Bin
Wu, Xinlin
Yang, Qiong
Huang, Yuanyuan
Wang, Fang
Gong, Yuxin
Liu, Junfang
Shi, Lin
author_facet Ke, Bin
Wu, Xinlin
Yang, Qiong
Huang, Yuanyuan
Wang, Fang
Gong, Yuxin
Liu, Junfang
Shi, Lin
author_sort Ke, Bin
collection PubMed
description Traditional Chinese Medicine (TCM) has been recognized to be conducive to enhancing the efficiency and reducing the side effects in the whole course of cancer treatment. The mechanisms of TCM/chemotherapy combination involved with interleukin-7 (IL-7) potentially enhance immune responses against tumor. In the present study, we emphasized on a herbal formulation Yi-qi-yang-yin-tian-sui-fang or TCM for short, and investigated its roles in chemotherapy in non-small cell lung cancer (NSCLC). The mice bared with tumor were treated with cisplatin (DDP) and simultaneously administrated with/without low, medium and high doses of TCMs (effective content: 0.5, 2.0 and 8.0 g/per mice) via oral gavage. The results indicated that combination of TCM further elevated the therapy efficiency of DDP in a dose-dependent manner. The growth of tumor cells was estimated by Ki-67 stain and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL) assay. The addition of TCM to the DDP treatment could significantly decrease the expression of Ki-67 and promote the apoptosis of tumor cells. In addition, the serum IL-7 level was down-regulated by DDP but restored by the treatment of TCM. The expression of IL-7 and its receptor IL-7R in tumor tissues was also recovered by TCM. Furthermore, the side effect from bone marrow suppression (myelosuppression) induced by DDP were assessed. TCM could abrogate DDP-induced apoptosis of bone marrow and also remarkably induced the expressions of IL-7 and hematopoietic growth factors including G-CSF, GM-CSF, SCF, and SDF-1 in bone marrow. These data indicated that this TCM combined with DDP showed superior anti-tumor effects with reduced myelosuppression via up-regulating IL-7.
format Online
Article
Text
id pubmed-6597844
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-65978442019-07-05 Yi-qi-yang-yin-tian-sui-fang enhances cisplatin-induced tumor eradication and inhibits interleukin-7 reduction in non-small cell lung cancer Ke, Bin Wu, Xinlin Yang, Qiong Huang, Yuanyuan Wang, Fang Gong, Yuxin Liu, Junfang Shi, Lin Biosci Rep Research Articles Traditional Chinese Medicine (TCM) has been recognized to be conducive to enhancing the efficiency and reducing the side effects in the whole course of cancer treatment. The mechanisms of TCM/chemotherapy combination involved with interleukin-7 (IL-7) potentially enhance immune responses against tumor. In the present study, we emphasized on a herbal formulation Yi-qi-yang-yin-tian-sui-fang or TCM for short, and investigated its roles in chemotherapy in non-small cell lung cancer (NSCLC). The mice bared with tumor were treated with cisplatin (DDP) and simultaneously administrated with/without low, medium and high doses of TCMs (effective content: 0.5, 2.0 and 8.0 g/per mice) via oral gavage. The results indicated that combination of TCM further elevated the therapy efficiency of DDP in a dose-dependent manner. The growth of tumor cells was estimated by Ki-67 stain and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL) assay. The addition of TCM to the DDP treatment could significantly decrease the expression of Ki-67 and promote the apoptosis of tumor cells. In addition, the serum IL-7 level was down-regulated by DDP but restored by the treatment of TCM. The expression of IL-7 and its receptor IL-7R in tumor tissues was also recovered by TCM. Furthermore, the side effect from bone marrow suppression (myelosuppression) induced by DDP were assessed. TCM could abrogate DDP-induced apoptosis of bone marrow and also remarkably induced the expressions of IL-7 and hematopoietic growth factors including G-CSF, GM-CSF, SCF, and SDF-1 in bone marrow. These data indicated that this TCM combined with DDP showed superior anti-tumor effects with reduced myelosuppression via up-regulating IL-7. Portland Press Ltd. 2019-06-28 /pmc/articles/PMC6597844/ /pubmed/31138762 http://dx.doi.org/10.1042/BSR20190052 Text en © 2019 The Author(s). http://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Articles
Ke, Bin
Wu, Xinlin
Yang, Qiong
Huang, Yuanyuan
Wang, Fang
Gong, Yuxin
Liu, Junfang
Shi, Lin
Yi-qi-yang-yin-tian-sui-fang enhances cisplatin-induced tumor eradication and inhibits interleukin-7 reduction in non-small cell lung cancer
title Yi-qi-yang-yin-tian-sui-fang enhances cisplatin-induced tumor eradication and inhibits interleukin-7 reduction in non-small cell lung cancer
title_full Yi-qi-yang-yin-tian-sui-fang enhances cisplatin-induced tumor eradication and inhibits interleukin-7 reduction in non-small cell lung cancer
title_fullStr Yi-qi-yang-yin-tian-sui-fang enhances cisplatin-induced tumor eradication and inhibits interleukin-7 reduction in non-small cell lung cancer
title_full_unstemmed Yi-qi-yang-yin-tian-sui-fang enhances cisplatin-induced tumor eradication and inhibits interleukin-7 reduction in non-small cell lung cancer
title_short Yi-qi-yang-yin-tian-sui-fang enhances cisplatin-induced tumor eradication and inhibits interleukin-7 reduction in non-small cell lung cancer
title_sort yi-qi-yang-yin-tian-sui-fang enhances cisplatin-induced tumor eradication and inhibits interleukin-7 reduction in non-small cell lung cancer
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597844/
https://www.ncbi.nlm.nih.gov/pubmed/31138762
http://dx.doi.org/10.1042/BSR20190052
work_keys_str_mv AT kebin yiqiyangyintiansuifangenhancescisplatininducedtumoreradicationandinhibitsinterleukin7reductioninnonsmallcelllungcancer
AT wuxinlin yiqiyangyintiansuifangenhancescisplatininducedtumoreradicationandinhibitsinterleukin7reductioninnonsmallcelllungcancer
AT yangqiong yiqiyangyintiansuifangenhancescisplatininducedtumoreradicationandinhibitsinterleukin7reductioninnonsmallcelllungcancer
AT huangyuanyuan yiqiyangyintiansuifangenhancescisplatininducedtumoreradicationandinhibitsinterleukin7reductioninnonsmallcelllungcancer
AT wangfang yiqiyangyintiansuifangenhancescisplatininducedtumoreradicationandinhibitsinterleukin7reductioninnonsmallcelllungcancer
AT gongyuxin yiqiyangyintiansuifangenhancescisplatininducedtumoreradicationandinhibitsinterleukin7reductioninnonsmallcelllungcancer
AT liujunfang yiqiyangyintiansuifangenhancescisplatininducedtumoreradicationandinhibitsinterleukin7reductioninnonsmallcelllungcancer
AT shilin yiqiyangyintiansuifangenhancescisplatininducedtumoreradicationandinhibitsinterleukin7reductioninnonsmallcelllungcancer